Speaker

Dr. Turner is Vice Chair for Clinical Research and Professor in the Department of Neurology, and Director of the Memory Disorders Program at Georgetown University, Washington, D.C. He received his doctorate and medical degrees from Emory University, Atlanta, followed by an internship in Internal Medicine, residency in Neurology, and a Howard Hughes Medical Institute-sponsored fellowship in behavioral neurology at the University of Pennsylvania, Philadelphia. He is board-certified in psychiatry and neurology. Prior to moving to Georgetown, he was Chief of the Neurology Service at the VA Ann Arbor Healthcare System and Associate Professor and Associate Chair in the Department of Neurology, University of Michigan, Ann Arbor. Dr. Turner directs the Memory Disorders Program at the MedStar Georgetown University Hospital. His research is focused on developing new treatments and biomarkers for neurodegenerative diseases of aging, particularly Mild Cognitive Impairment and dementia due to Alzheimer’s disease. He has published over 100 peer-reviewed papers, reviews, and book chapters. Dr. Turner is on the steering committees of the Alzheimer’s Disease Cooperative Study (ADCS) and the Alzheimer’s Therapeutic Research Institute (ATRI), and is a site PI for the NIH-funded Alzheimer’s Clinical Trials Consortium (ACTC) and Trial-Ready Cohort for Preclinical/Prodromal Alzheimer’s Disease (TRC-PAD). He is PI or Site PI on numerous multi-center, randomized, placebo-controlled clinical trials.